A new method for the determination of arylesterase activity in human serum using simulated body fluid.
Arylesterase activity (EC 3.1.1.2), one of the three functions of the paraoxonase enzyme (PON1), is thought to protect low-density lipoproteins (LDL) and high-density lipoprotein (HDL) from oxidation and to facilitate reverse cholesterol transport. The Eckerson et al. method, which employs Tris/HCl buffer, has been extensively used and could be considered as the reference method, although it shows relatively low precision and reproducibility. Using simulated body fluid (SBF), which simulates blood electrolyte composition, a significant improvement in arylesterase activity determination was achieved. Modifications of SBF bicarbonate and chloride concentrations did not result in further improvements. To validate this method arylesterase activity was measured using SBF and Tris/HCl in 23 subjects with increased cardiovascular disease risk. Precision was significantly higher using SBF than with Tris/HCl. Data from both methods do not significantly differ in samples with arylesterase activity > or = 30.6 U/L using SBF, but do differ significantly when very low activity samples (< 30.6 U/L) were included. Differences suggest that the Tris/HCl buffer gives misleading activity results, especially in very low activity samples. For the first time, results suggest that SBF can successfully be used instead of Tris/HCl in arylesterase activity determination.
Nus
Meritxell
M
Departamento de Nutrición y Bromatología I (Nutrición), Facultad de Farmacia. Universidad Complutense, Madrid, Spain.
Sánchez-Muniz
Francisco J
FJ
Sánchez-Montero
José M
JM
D001826:Body Fluids; D002265:Carboxylic Ester Hydrolases / Q000097:blood*; D006801:Humans; D025202:Molecular Diagnostic Techniques; D010648:Phenylacetates / Q000737:chemistry; D012680:Sensitivity and Specificity
D010648:Phenylacetates; D002265:Carboxylic Ester Hydrolases; C019734:arylesterase; C025136:phenylacetic acid